| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 203 companies in the Health Care Equipment & Supplies industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 11, 2024 | WRBY Warby Parker Inc. | Miller Steven Clive64 | Chief Financial Officer | Sell | 6,763 | $13.90 | $94,005.70 | -3.7% | +67.6% | +96.2% | |
| Sep 11, 2024 | EW Edwards Lifesciences Corp | Bobo Donald E Jr64 | Cvp,Strategy/ Corp Development | Sell | 5,000 | $66.77 | $333,825.50 | -9.6% | +7.5% | +14.3% | |
| Sep 11, 2024 | LIVN Livanova Plc | Bianchi Francesco | Director | Sell | 1,500 | $46.58 | $69,870.00 | -14.6% | +5.5% | +20.8% | |
| Sep 11, 2024 | COCH Envoy Medical, Inc. | Patel Mona Chetan | Director | Buy | 5,000 | $3.30 | $16,520.00 | +500.0% | -32.7% | -58.2% | |
| Sep 10, 2024 | SERA Sera Prognostics, Inc. | Lindgardt Zhenya75 | Chief Executive Officer | Sell | 25,085 | $7.57 | $189,893.45 | -2.9% | +3.6% | -58.5% | |
| Sep 10, 2024 | STE Steris Plc | Tokich Michael J65 | Sr. Vice Pres., CFO | Sell | 23,332 | $247.00 | $5,763,004.00 | -35.2% | -12.8% | -1.4% | |
| Sep 10, 2024 | RGEN Repligen Corp | Hunt Anthony75 | Director | Sell | 22,191 | $145.37 | $3,225,927.40 | -3.6% | +5.5% | -18.0% | |
| Sep 10, 2024 | TLSI Trisalus Life Sciences, Inc. | Szela Mary T47 | CEO And President | Buy | 5,000 | $4.97 | $24,850.00 | +1.4% | -16.2% | -5.2% | |
| Sep 10, 2024 | PODD Insulet Corp | Scannell Timothy J | Director | Sell | 5,000 | $225.84 | $1,129,200.00 | -14.1% | +17.1% | +49.1% | |
| Sep 10, 2024 | RVP Retractable Technologies Inc | Shaw Thomas J50 | President And CEO | Buy | 8,577 | $0.91 | $7,811.93 | - | -29.6% | -9.0% | |
| Sep 10, 2024 | ISRG Intuitive Surgical Inc | Desantis Robert49 | EVP &Chief Strategy &Corp Op | Sell | 238 | $477.50 | $113,645.00 | -2.1% | +11.3% | -7.1% | |
| Sep 10, 2024 | SERA Sera Prognostics, Inc. | Aerts Austin77 | Chief Financial Officer | Sell | 5,056 | $7.57 | $38,273.92 | -1.7% | +3.6% | -58.5% | |
| Sep 10, 2024 | SSII Ss Innovations International, Inc. | Cohen Barry F | COO - Americas | Buy | 622 | $3.91 | $2,429.50 | - | - | - | |
| Sep 10, 2024 | WRBY Warby Parker Inc. | Gilboa David Abraham62 | Co-chief Executive Officer | Sell | 76,177 | $13.44 | $1,024,134.46 | -75.6% | +69.3% | +94.6% | |
| Sep 10, 2024 | COO Cooper Companies, Inc. | Ricupati Agostino62 | SVP &CAO | Sell | 1,601 | $108.03 | $172,955.23 | -24.9% | -8.4% | -37.5% | |
| Sep 9, 2024 | DXCM Dexcom Inc | Leach Jacob Steven55 | EVP, Chief Operating Officer | Sell | 746 | $69.15 | $51,585.90 | -0.3% | +12.5% | +12.5% | |
| Sep 9, 2024 | DXCM Dexcom Inc | Sylvain Jereme M65 | EVP, Chief Financal Officer | Sell | 746 | $69.15 | $51,585.90 | -0.9% | +12.5% | +12.5% | |
| Sep 9, 2024 | GKOS Glaukos Corp | Kliman Gilbert H64 | - | Sell | 3,000 | $130.67 | $392,000.00 | -4.4% | +7.2% | -29.7% | |
| Sep 9, 2024 | RMD Resmed Inc | Sandercock Brett62 | Chief Financial Officer | Sell | 1,000 | $246.42 | $246,420.00 | -1.0% | -1.9% | +11.9% | |
| Sep 9, 2024 | PODD Insulet Corp | Field Mark N | SVP &Chief Technology Officer | Sell | 1,383 | $220.87 | $305,463.21 | -12.4% | +21.0% | +61.0% | |
| Sep 9, 2024 | DXCM Dexcom Inc | Stern Sadie72 | EVP, Chief Hr Officer | Sell | 426 | $69.15 | $29,457.90 | -0.6% | +12.5% | +12.5% | |
| Sep 9, 2024 | INSP Inspire Medical Systems, Inc. | McCormick Shawn78 | Director | Sell | 800 | $220.00 | $176,000.00 | -3.3% | -10.4% | -61.5% | |
| Sep 9, 2024 | RMD Resmed Inc | Farrell Michael J.63 | Chief Executive Officer | Sell | 14,683 | $248.38 | $3,646,950.33 | -3.1% | -1.9% | +11.9% | |
| Sep 9, 2024 | INSP Inspire Medical Systems, Inc. | Rondoni John79 | Chief Technology Officer | Sell | 31 | $215.00 | $6,665.00 | -0.3% | -10.4% | -61.5% | |
| Sep 9, 2024 | ATR Aptargroup, Inc. | Touya Gael61 | Segment President | Sell | 3,300 | $151.62 | $500,338.08 | -9.3% | +12.4% | -9.8% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.